Biotech

Cold Spring Harbor Laboratory's Technology Transfer Chief Teri Willey

The Debrief: Teri Willey, Cold Spring Harbor Lab

Venture capitalization veteran Teri Willey came to Cold Spring Harbor Laboratory 18 months ago on a mission: to turn the lab’s life-altering science into bona fide business. As co-founder of seed venture fund ARCH Development Partners, VP of Technology & Business Development at Mount Sinai Medical Center and past president of the Association of University Technology Managers, among other distinguished positions, the University of Idaho graduate (with an MBA from Indiana State) had already shepherded…


CSHL's Bruce Stillman

North Shore-LIJ, CSHL in cancer partnership

Cold Spring Harbor Laboratory and North Shore-LIJ announced a joint cancer research and treatment effort that is designed to speed the region’s most-promising research to patients. The affiliation will better connect researchers at CSHL and North Shore’s Feinstein Institute for Medical Research and provide patients for clinical trials of the latest treatments, linking scieentists with more than 200 oncologists at North Shore-LIJ’s Cancer Institute. Cold Spring Harbor CEO Bruce Stillman called the paertnership a “transformative…


SBU

SBU, Cold Spring and BNL win hub grant

A $3 million grant from the National Institutes of Health will help Long Island’s three premier biotech R&D facilities speed medical breakthroughs to market. The NIH announced April 8 that it was awarding Stony Brook University’s Center for Biotechnology a three-year grant to help establish the Long Island Bioscience Hub in collaboration with Cold Spring Harbor Laboratory and Brookhaven National Laboratory in Upton. The hub will look to turn biomedical discoveries made at the three…


Bioscience Park

Lights back on, finally, at Bioscience Park

Biotech firm Codagenix, a fixture at Stony Brook’s technology incubator for the past three years, is moving to the Broad Hollow Bioscience Park at SUNY Farmingdale to qualify for the state’s Start-Up NY program. (Additional reason for the move: Robert Coleman, the Codagenix COO, is an assistant professor of biology at Farmingdale.) Codagenix uses proprietary software to genetically re-code viruses, which are then synthesized from scratch as treatment candidates – one is a promising flu…


DepYMed CEO Andreas Grill

Clinical trials for DepYMed

A joint venture between biotech stalwart Ohr Pharmaceutical and Cold Spring Harbor Laboratory is taking the fight to breast cancer – though a revolutionary treatment may still be a half-decade away at least. Cold Spring Harbor-based DepYMed, which incorporated just 10 months ago, is eyeing the first clinical trials of an enzyme inhibitor the company is proffering as a potential breakthrough for patients with HER2-positive breast cancer – a cancer that causes uncontrolled amplification in…


Ryan, former Forest veep, named to CSHL post

Cold Spring Harbor Laboratory has added another major-league bat to its commercialization lineup. Charles Ryan, former senior vice president and chief intellectual property counsel at Forest Laboratories, is CSHL’s new general counsel, bringing a wealth of experience in patent law and partnering agreements to the cutting-edge R&D facility. “I’m very excited about this opportunity,” Ryan told Innovate-LI. “Long Island is an incredible place to do science and to do business, and there’s no place on…